Telmisartan and Rosuvastatin Tablets 40/10 mg

Adult dose

Telmisartan: The recommended oral dose for adults is 40 mg once daily, and depending on the patient's condition, 20 mg once daily may be effective. If needed, the dose may be increased up to 80 mg once daily. For the purpose of reducing the risk of cardiovascular disease, an oral dose of 80 mg once daily is recommended. Patients with liver impairment (mild to moderate) should not exceed 40 mg once daily. Rosuvastatin Calcium: The initial dose is 5 mg once daily.

This medication may cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be taken by individuals with hypersensitivity to this medication, pregnant women, nursing women, or fertile women not using appropriate contraception. Caution is required when administering this medication to patients with severe liver impairment or issues with bile excretion. In patients with a history of muscle disease or severe renal failure, use may be prohibited or require careful observation. Elderly patients, patients with hyperkalemia, and patients with mild liver impairment should use this medication with special caution. If muscle pain or weakness occurs, consult a physician immediately, and in severe cases, discontinue use. Regular monitoring of liver function tests and blood enzyme levels is necessary; if abnormalities are detected, discontinuation may be warranted. This medication may interact with other drugs, so if you are taking any other medications, inform your physician or pharmacist. Caution is necessary while driving or operating machinery as dizziness may occur. It is not recommended for children, as safety and efficacy have not been established. In case of overdose, symptoms such as hypotension, dizziness, and renal impairment may occur, so immediate medical attention is necessary. This drug should be kept out of the reach of children and should not be transferred to another container.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, sweating, pallor, severe rash with fever, blisters, skin peeling, mucosal pain in the mouth/eyes, shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual abnormalities, paralysis, and urinary issues.

Mild side effects

• Dyspepsia
• oral paresthesia
• musculoskeletal stiffness
• acne
• itching
• dizziness
• nasopharyngitis
• dysuria
• rhinitis
• pharyngeal discomfort

Store this medication in a tightly closed container to protect it from air or moisture. It is best to keep it at room temperature between 1°C and 30°C.

Appearance

Light orange oval film-coated tablets

Package unit

30 tablets/box [(10 tablets/PTPX3)]